NKGN — Nkgen Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Nkgen Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.351	0.117	0.026	0.106
Net Total Accounts Receivable
Net Total Receivables	0.067	0.096	0.026	0.024
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.612	0.35	1.93	2.46
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.4	15.9	14.5	13.7
Net Intangible Assets
Total Assets	18.1	16.3	16.5	16.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	55.7	14.7	39.5	58
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	56.1	14.8	75.2	86.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-38.1	1.56	-58.7	-69.9
Total Liabilities & Shareholders' Equity	18.1	16.3	16.5	16.2
Total Common Shares Outstanding